India markets closed

Takeda Pharmaceutical Company Limited (TAK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
18.15-0.04 (-0.22%)
At close: 4:00PM EDT

18.26 +0.11 (0.61%)
After hours: 5:10PM EDT

Full screen
Trade prices are not sourced from all markets
Previous close18.19
Open18.40
Bid18.10 x 1800
Ask18.26 x 1000
Day's range18.10 - 18.40
52-week range12.43 - 20.93
Volume793,485
Avg. volume1,138,092
Market cap56.981B
Beta (5Y monthly)1.09
PE ratio (TTM)22.37
EPS (TTM)0.81
Earnings dateN/A
Forward dividend & yield0.84 (4.61%)
Ex-dividend date30-Mar-2020
1y target est23.60
  • Coronavirus update: NY's Cuomo OKs sending students back to school as vaccine optimism rises
    Editor's pick
    Yahoo Finance

    Coronavirus update: NY's Cuomo OKs sending students back to school as vaccine optimism rises

    New York’s school districts will welcome students back into classrooms in the fall, Governor Andrew Cuomo announced on Friday, as the former coronavirus epicenter continues on its recovery.

  • Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan
    Business Wire

    Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan

    Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK), today announced a partnership for the development, manufacturing and commercialization of NVX‑CoV2373, Novavax’ COVID‑19 vaccine candidate, in Japan. NVX‑CoV2373 is a stable, prefusion protein made using Novavax’ recombinant protein nanoparticle technology and includes Novavax’ proprietary Matrix‑M™ adjuvant. Takeda will receive funding from the Government of Japan’s Ministry of Health, Labour and Welfare (MHLW) to support the technology transfer, establishment of infrastructure and scale-up of manufacturing. Takeda anticipates the capacity to manufacture over 250 million doses of the COVID-19 vaccine per year1.

  • BioLife Plasma Services Announces Opening of First Plasma Collection Center in Louisiana
    Business Wire

    BioLife Plasma Services Announces Opening of First Plasma Collection Center in Louisiana

    BioLife Plasma Services announces opening of first plasma collection center in Louisiana.